menu
    • menu

    Company profile for Laekna Therapeutics

    NEW Drugs in Dev: 8
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in December 2016, Laekna Therapeutics is a startup biotech company focusing on innovative drug discovery and development, we are dedicated to developing new targeted therapies to treat cancer and liver diseases. Laekna has strong expertise in both small molecule and antibody discovery and development. Drs. Chris Lu and Yong Yue, and the rest of the leadership team have extensive R&D and management experience in global...
    Founded in December 2016, Laekna Therapeutics is a startup biotech company focusing on innovative drug discovery and development, we are dedicated to developing new targeted therapies to treat cancer and liver diseases. Laekna has strong expertise in both small molecule and antibody discovery and development. Drs. Chris Lu and Yong Yue, and the rest of the leadership team have extensive R&D and management experience in global pharmaceutical companies, along with an exceptional track record of new drug approval and marketing. Laekna is a company full of energy and innovation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Laekna TherapeuticsChina Flag
    Country
    Country
    China
    Address
    Address
    5th Floor, 987 Cailun Road, Zhangjiang, Pudong, Shanghai
    Telephone
    Telephone
    +86（21）50716089
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.laeknatp.com/about?_l=en
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Laekna Presents Studies Results of LAE102, LAE103, and LAE123
    Laekna Presents Studies Results of LAE102, LAE103, and LAE123

    23 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250623952873/en/ADA-2025-Laekna-Presented-Clinical-and-Pre-clinical-Studies-Results-of-LAE102-LAE103-and-LAE123

    BUSINESSWIRE
    23 Jun 2025
    Share Share
    Laekna Gets FDA IND Nod for LAE120 in Solid Tumors
    Laekna Gets FDA IND Nod for LAE120 in Solid Tumors

    03 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250303151589/en

    BUSINESSWIRE
    03 Mar 2025
    Share Share
    Laekna with Lilly to develop muscle preserving obesity drug
    Laekna with Lilly to develop muscle preserving obesity drug

    21 Nov 2024

    // PRESS RELEASE

    https://en.laekna.com/new/431.html

    PRESS RELEASE
    21 Nov 2024
    Share Share
    Laekna Lae002 Lae001 Approval: Fda Phase 3 Prostate Cancer Trial
    Laekna Lae002 Lae001 Approval: Fda Phase 3 Prostate Cancer Trial

    23 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/laekna-announces-fda-approval-for-the-phase-iii-clinical-trial-protocol-of-lae002-afuresertib-plus-lae001-for-the-treatment-of-prostate-cancer-302154036.html

    PR NEWSWIRE
    23 May 2024
    Share Share
    Laekna Announces Poster Presentations on Discovered Drug Candidates at AACR 2024
    Laekna Announces Poster Presentations on Discovered Drug Candidates at AACR 2024

    07 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/laekna-announces-two-poster-presentations-on-internally-discovered-drug-candidates-at-aacr-2024-302109861.html

    PR NEWSWIRE
    07 Apr 2024
    Share Share
    Laekna Announces Poster Presentation on Internally-Discovered Antibody for NASH
    Laekna Announces Poster Presentation on Internally-Discovered Antibody for NASH

    03 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/

    PR NEWSWIRE
    03 Jan 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search